Loading...
Uploaded by TaipanFinancialNews on May 10, 2007
http://www.taipanfinancialnews.com/signupsingle/tfnenewsvideoexternal.html -- Biogeneric legislation is working its way through Washington. This is a $50 billion industry that could soar in value overnight. This bill could be a major opportunity for a handful of generic manufacturers. Paste this link into your browser to have TFN videos like this emailed directly to your inbox each day: http://www.taipanfinancialnews.com/signupsingle/tfnenewsvideoexternal.html
News & Politics
Standard YouTube License
Another great play as far as small companies that are poised for growth once the biogenerics bill passes is Insmed..
FOBNOW2008 4 years ago
Load more suggestions
Another great play as far as small companies that are poised for growth once the biogenerics bill passes is Insmed..
FOBNOW2008 4 years ago